首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   607篇
  免费   22篇
耳鼻咽喉   8篇
儿科学   24篇
妇产科学   13篇
基础医学   50篇
口腔科学   3篇
临床医学   41篇
内科学   124篇
皮肤病学   28篇
神经病学   25篇
特种医学   1篇
外科学   69篇
综合类   174篇
一般理论   1篇
预防医学   14篇
眼科学   2篇
药学   35篇
肿瘤学   17篇
  2021年   4篇
  2017年   3篇
  2016年   5篇
  2015年   15篇
  2014年   6篇
  2013年   10篇
  2011年   4篇
  2010年   19篇
  2009年   25篇
  2007年   5篇
  2006年   10篇
  2005年   5篇
  2002年   8篇
  2001年   33篇
  2000年   24篇
  1999年   32篇
  1998年   17篇
  1997年   21篇
  1996年   27篇
  1995年   26篇
  1994年   19篇
  1993年   11篇
  1992年   14篇
  1991年   12篇
  1990年   6篇
  1989年   10篇
  1988年   5篇
  1987年   10篇
  1986年   5篇
  1985年   7篇
  1984年   10篇
  1983年   8篇
  1982年   8篇
  1981年   6篇
  1980年   6篇
  1979年   7篇
  1978年   6篇
  1977年   7篇
  1975年   4篇
  1973年   4篇
  1966年   2篇
  1960年   4篇
  1959年   13篇
  1958年   18篇
  1957年   26篇
  1956年   23篇
  1955年   19篇
  1954年   22篇
  1949年   8篇
  1948年   6篇
排序方式: 共有629条查询结果,搜索用时 15 毫秒
21.
22.
23.
24.
25.
26.
27.
One thousand, nine hundred and seventy-seven patients with squamous carcinoma of the head and neck are reviewed with particular reference to the patients not treated. The commonest reason for not treating the patients was that the tumour was too extensive (55%). A further 36% were too old or infirm to be considered fit for radical treatment, and 9% of patients refused treatment. Treated and untreated patients were compared for age, sex, site of the primary and TNM stage. The proportion of patients untreated varied according to site of the primary tumour, with 25% of pharangeal tumours being the highest proportional representation. Median survival for untreated patients was 88 days; survival time was significantly related to sex, T stage of primary tumour and patient's general condition.  相似文献   
28.
29.
Factor structure of the Motivation Assessment Scale   总被引:3,自引:0,他引:3  
The Motivation Assessment Scale (MAS) was developed to provide clinical information on four hypothesized functions that may control problem behaviour in persons with developmental disabilities. The original four-factor structure of the MAS was based on face validity, with the items being grouped in terms of each of the hypothesized functions. Validation of the scale was provided in terms of correlations between teacher ratings of eight children on the MAS and ranking of the controlling variables from functional analogue tests. In this study, staff in residential facilities rated 60 residents and teachers in schools rated 96 students on the MAS. The target behaviour rated for both samples was self-injury, with the institutional sample engaging in the behaviour more than 15 times an hour and the school sample, less than 15 times an hour. The results of factor analyses, with varimax rotation, provided a conceptually meaningful factor structure with the institutional sample, but not with the school sample. The 16 MAS items resolved into four factors that were conceptually related to four conditions that may maintain problem behaviour (i.e. sensory, escape, attention and tangible). The results suggested that the original MAS has a robust factor structure and may be clinically useful in predicting the controlling functions of problem behaviours, if the target behaviours occur at a rate no less than 15 responses per hour.  相似文献   
30.
Protein patterns of cultured fibroblasts and hair root lysates from healthy controls and patients with genetic diseases (Duchenne muscular dystrophy, Friedreich's ataxia, Marie's ataxia, Lesch-Nyhan syndrome, maple syrup urine disease, and trisomy 13, 18 and 21) were obtained with two-dimensional electrophoresis. The analysis of these patterns in 39 gels by visual comparison revealed differences in the presence and absence of 20 specific protein spots. However, this variability, which has been observed in healthy controls as well as in patients, could not provide a diagnosis for a specific genetic disease. Only in one case - trisomy 18 - was an additional spot observed, which was not present in any of the other gels.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号